Retinal detachment repair by vitrectomy: Simplified formulae to estimate the risk of failure

British Journal of Ophthalmology

Volumn 95, Issue 9, 2011, Pages 1239-1244

  Wickham, L ^a   Bunce, C ^a   Wong, D ^b   Charteris, D G ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; CATARACT EXTRACTION; DIAGNOSTIC VALUE; EYE SURGERY; FEMALE; HUMAN; LENS EXTRACTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PARS PLANA VITRECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; RETINA DETACHMENT; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TREATMENT FAILURE; VITRECTOMY; VITREORETINOPATHY; VITREOUS HEMORRHAGE;

ADULT; AGED; ANTIMETABOLITES; FEMALE; FIBRINOLYTIC AGENTS; FLUOROURACIL; FOLLOW-UP STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RETINAL DETACHMENT; RISK ASSESSMENT; RISK FACTORS; TREATMENT FAILURE; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 80052105632     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.190314     Document Type: Article

References (24)

1. Heimann H, Bornfeld N, Friedrichs W, et al. Primary vitrectomy without scleral buckling for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 1996;234:561-8.
2. Girard P, Karpouzas I. Pseudophakic retinal detachment: anatomic and visual results. Graefes Arch Clin Exp Ophthalmol 1995;233:324-30.
3. Halberstadt M, Brandenburg L, Sans N, et al. Analysis of risk factors for the outcome of primary retinal reattachment surgery in phakic and pseudophakic eyes. Klin Monatsbl Augenheilkd 2003;220:116-21.
4. Schmidt JC, Rodrigues EB, Hoerle S, et al. Primary vitrectomy in complicated rhegmatogenous retinal detachment - a survey of 205 eyes. Ophthalmologica 2003;217:387-92.
5. Thompson JA, Snead MP, Billington BM, et al. National audit of the outcome of primary surgery for rhegmatogenous retinal detachment. II. Clinical outcomes. Eye 2002;16:771-7.
6. Campo RV, Sipperley JO, Sneed SR, et al. Pars plana vitrectomy without scleral buckle for pseudophakic retinal detachments. Ophthalmology 1999;106:1811-16.
7. Lewis H, Aaberg TM. Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy. Am J Ophthalmol 1991;111:15-19.
8. Lewis H, Aaberg TM, Abrams GW. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol 1991;111:8-14.
9. Silicone Study Group. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Arch Ophthalmol 1992;110:780-92.
10. Silicone Study Group. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone study report 1. Arch Ophthalmol 1992;110:770-9.
11. Chignell AH, Fison LG, Davies EWG, et al. Failure in retinal detachment surgery. Br J Ophthalmol 1973;57:525-30.
12. Sullivan PM, Luff AJ, Aylward GW. Results of primary retinal reattachment surgery: a prospective audit. Eye 1997;11:869-71.
13. Sanderson Grizzard J, Hilton GF, Hammer ME, et al. A multivariate analysis of anatomic success of retinal detachments treated with scleral buckling. Graefes Arch Clin Exp Ophthalmol 1994;232:1-7.
14. Kon CH, Asaria RH, Occleston NL, et al. Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br J Ophthalmol 2000;84:506-11.
15. Girard P, Mimoun G, Karpouzas I, et al. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 1994;14:417-24.
16. Duquesne N, Bonnet M, Adeleine P. Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 1996;234:677-82.
17. Yoshino Y, Ideta H, Nagasaki H, et al. Comparative study of clinical factors predisposing patients to proliferative vitreoretinopathy. Retina 1989;9:97-100.
18. Asaria RH, Kon CH, Bunce C, et al. How to predict proliferative vitreoretinopathy - A prospective study. Ophthalmology 2001;108:1184-6.
19. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004;23:1631-60.
20. Wickham L, Bunce C, Wong D, et al. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology 2007;114:698-704.
21. Tseng W, Cortez RT, Ramirez G, et al. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous surgery. Am J Ophthalmol 2004;137:1105-15.
22. Machemer R, Aaberg TM, Freeman HM, et al. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1991;112:159-65.
23. Rodriguez de la Rua E, Pastor JC, Mayo-Iscar A, et al. Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy. Curr Eye Res 2005;30:147-53.
24. Wickham L, Asaria RH, Alexander R, et al. Immunopathology of intraocular silicone oil: enucleated eyes. Br J Ophthalmol 2007;91:253-7.